Ad
AVXL Stock Quote Trading Chart Anavex Life Sciences Corp.
home / stock / avxl / avxl quote
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
| Last: | $6.36 |
|---|---|
| Change Percent: | -0.31% |
| Open: | $6.57 |
| Close: | $6.36 |
| High: | $6.63 |
| Low: | $6.29 |
| Volume: | 826,881 |
| Last Trade Date Time: | 10/02/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
AVXL Last Five Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $6.36 | $6.57 | $6.36 | $6.63 | $6.29 | 826,881 | 10-02-2023 |
| $6.55 | $6.81 | $6.55 | $6.85 | $6.515 | 898,145 | 09-29-2023 |
| $6.72 | $6.81 | $6.72 | $6.82 | $6.6 | 607,717 | 09-28-2023 |
| $6.81 | $6.83 | $6.81 | $6.95 | $6.665 | 547,953 | 09-27-2023 |
| $6.8 | $6.74 | $6.8 | $7.04 | $6.74 | 606,126 | 09-26-2023 |
| $6.79 | $6.85 | $6.79 | $6.9101 | $6.7499 | 549,032 | 09-25-2023 |
| $6.89 | $7 | $6.89 | $7 | $6.84 | 668,733 | 09-22-2023 |
| $6.97 | $7.13 | $6.97 | $7.2 | $6.86 | 768,865 | 09-21-2023 |
| $7.24 | $7.12 | $7.24 | $7.92 | $7.07 | 1,467,088 | 09-20-2023 |
| $7.12 | $7.12 | $7.12 | $7.13 | $6.81 | 1,119,280 | 09-19-2023 |
| $7.13 | $7.79 | $7.13 | $7.84 | $7.065 | 1,660,138 | 09-18-2023 |
| $7.57 | $8 | $7.57 | $8.0299 | $7.55 | 2,941,032 | 09-15-2023 |
| $7.95 | $7.98 | $7.95 | $8.3899 | $7.57 | 2,770,282 | 09-14-2023 |
| $7.66 | $7.73 | $7.66 | $8.02 | $7.64 | 738,376 | 09-13-2023 |
| $7.75 | $7.75 | $7.75 | $7.85 | $7.67 | 656,619 | 09-12-2023 |
| $7.75 | $7.87 | $7.75 | $7.9 | $7.65 | 626,961 | 09-11-2023 |
| $7.87 | $7.72 | $7.87 | $7.88 | $7.64 | 653,361 | 09-08-2023 |
| $7.71 | $7.75 | $7.71 | $7.83 | $7.68 | 798,330 | 09-07-2023 |
| $7.81 | $7.84 | $7.81 | $7.89 | $7.71 | 672,631 | 09-06-2023 |
| $7.87 | $7.92 | $7.87 | $8.02 | $7.8 | 573,983 | 09-05-2023 |
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Ad
-
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
-
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceu...
-
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...